- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.02. | Share in cystic fibrosis firm Sionna rise sharply after IPO | ||
| 10.02. | NIH indirect funding cuts appals medical research groups | ||
| 07.02. | USAID could see workforce cut to 600 as stop-work looms | ||
| 07.02. | Bain buys Japanese pharma Mitsubishi Tanabe for $3.4bn | ||
| 07.02. | MSD starts pivotal trial of ROR1 drug in first-line lymphoma | ||
| 07.02. | FDA starts review of first bronchiectasis drug candidate | ||
| 07.02. | Trump 'planning mass job cuts at US health agencies' | ||
| 06.02. | BMS extends its cost-cutting drive by another $2bn | ||
| 06.02. | Pressure relieved on AZ as details of Chinese probe emerge | ||
| 06.02. | Newel's VR therapy for chronic pain nears EU market | ||
| 06.02. | Pharma group slams Hims & Hers over Super Bowl GLP-1 ad | ||
| 06.02. | Novo charts course ahead for CagriSema after lacklustre data | ||
| 05.02. | FDA expands label for Roche's eye disease implant Susvimo | ||
| 05.02. | GSK rides out vaccine sales weakness with cancer, HIV gains | ||
| 05.02. | Liva buys Momenta to bolster digital health platform | ||
| 05.02. | Novo rises on Wegovy sales leap, but warns of a slowdown | ||
| 05.02. | RFK Jr odds on for HHS role after Finance Committee vote | ||
| 04.02. | Algiax non-opioid drug works in chronic neuropathic pain | ||
| 04.02. | NHS trial puts AI for breast cancer screening under scrutiny | ||
| 04.02. | GH Research leaps on psychedelic data in depression | ||
| 04.02. | Pfizer builds on Braftovi bowel cancer OK with survival data | ||
| 04.02. | Trump tariffs 'would strain the pharma supply chain' | ||
| 03.02. | Bayer files finerenone in EU for heart failure | ||
| 03.02. | Report says AZ's UK plant decision is not just about funding | ||
| 03.02. | USAID site offline as Musk says it should be shut down |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
